Arcadia Biosciences, Inc. — Director's Dealing 2021

May 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2021-05-17

Reporting Person: Cuvelier Chris (Chief Growth Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-17	Stock Option (right to buy)	$2.61	A	100000	Acquired	2031-05-17	Common Stock (100000)	Direct

Footnotes

F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.